Abstract:Abstract Research into lipoprotein metabolism has developed because understanding lipoprotein metabolism has important clinical indications. Lipoproteins are risk factors for cardiovascular disease. Recent advances include the identification of factors in the synthesis and secretion of triglyceride rich lipoproteins, chylomicrons (CM) and very low density lipoproteins (VLDL). These included the identification of microsomal transfer protein, the cotranslational targeting of apoproteinB (apoB) for degradation regulated by the availability of lipids, and the characterization of transport vesicles transporting primordial apoB containing particles to the Golgi. The lipase maturation factor 1, glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 and an angiopoietin-like protein play a role in lipoprotein lipase (LPL)-mediated hydrolysis of secreted CMs and VLDL so that the right amount of fatty acid is delivered to the right tissue at the right time. Expression of the low density lipoprotein (LDL) receptor is regulated at both transcriptional and post-transcriptional level. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has a pivotal role in the degradation of LDL receptor. Plasma remnant lipoproteins bind to specific receptors in the liver, the LDL receptor, VLDL receptor and LDL receptor-like proteins prior to removal from the plasma. Reverse cholesterol transport occurs when lipid free apoAI recruits cholesterol and phospholipid to assemble high density lipoprotein (HDL) particles. The discovery of ABC transporters (ABCA1 and ABCG1) and scavenger receptor class B type I (SR-BI) provided further information on the biogenesis of HDL. In humans HDL-cholesterol can be returned to the liver either by direct uptake by SR-BI or through cholesteryl ester transfer protein exchange of cholesteryl ester for triglycerides in apoB lipoproteins, followed by hepatic uptake of apoB containing particles. Cholesterol content in cells is regulated by several transcription factors, including the liver X receptor and sterol regulatory element binding protein. This review summarizes recent advances in knowledge of the molecular mechanisms regulating lipoprotein metabolism.

Recent Advance on Hormone Sensitive Lipase

Structural Insights of a Hormone Sensitive Lipase Homologue Est22

Important Hormones Regulating Lipid Metabolism

[The Integration and Regulation of Hormone-Sensitive Lipase in Reproductive System].

Efficient Screening of Pancreatic Lipase Inhibitors from Rheum Palmatum by Affinity Ultrafiltration-High-performance Liquid Chromatography Combined with High-Resolution Inhibition Profiling

Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway

Expression, Purification, And Lipolytic Activity Of Recombinant Human Serum Albumin Fusion Proteins With One Domain Of Human Growth Hormone In Pichia Pastoris

Comparative Analyses Of Lipoprotein Lipase, Hepatic Lipase, And Endothelial Lipase, And Their Binding Properties With Known Inhibitors

Recent advance of fatty acid synthetase inhibitor

Adipose tissue lipid metabolism: lipolysis

Research and development of Lipin family

Research progress in lipid metabolic regulation of bioactive peptides

Lipoprotein Lipase and Its Regulators: an Unfolding Story.

Structural Basis for the Regiospecificity of a Lipase from Streptomyces sp. W007

Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases

Identification and Biochemical Characterization of a Novel Hormone-Sensitive Lipase Family Esterase Est19 from the Antarctic Bacterium Pseudomonas sp. E2-15

Propeptide-mediated protein folding:mechanism and its impact on lipase

Recent Advances on Adiponectin Receptor

Enzyme engineering for functional lipids synthesis: recent advance and perspective

Structural characteristics and catalysis properties of a dual-functional enzyme Lip10 from Mucor circinelloides

Recent advances in physiological lipoprotein metabolism